129 related articles for article (PubMed ID: 36542027)
1. Increased levels of N6-methyladenosine in peripheral blood RNA: a perspective diagnostic biomarker and therapeutic target for non-small cell lung cancer.
Yin H; Hong H; Yin P; Lu W; Niu S; Chen X; Xia Y; Jiang P; Huang Z
Clin Chem Lab Med; 2023 Feb; 61(3):473-484. PubMed ID: 36542027
[TBL] [Abstract][Full Text] [Related]
2. Elevated N6-Methyladenosine RNA Levels in Peripheral Blood Immune Cells: A Novel Predictive Biomarker and Therapeutic Target for Colorectal Cancer.
Xie J; Huang Z; Jiang P; Wu R; Jiang H; Luo C; Hong H; Yin H
Front Immunol; 2021; 12():760747. PubMed ID: 34659267
[TBL] [Abstract][Full Text] [Related]
3. FTO facilitates cancer metastasis by modifying the m
Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
[TBL] [Abstract][Full Text] [Related]
4. Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer.
Ge L; Zhang N; Chen Z; Song J; Wu Y; Li Z; Chen F; Wu J; Li D; Li J; Wang C; Wang H; Wang J
Clin Chem; 2020 Feb; 66(2):342-351. PubMed ID: 32040577
[TBL] [Abstract][Full Text] [Related]
5. Peripheral Blood Leukocyte N6-methyladenosine is a Noninvasive Biomarker for Non-small-cell Lung Carcinoma.
Pei Y; Lou X; Li K; Xu X; Guo Y; Xu D; Yang Z; Xu D; Cui W; Zhang D
Onco Targets Ther; 2020; 13():11913-11921. PubMed ID: 33239892
[TBL] [Abstract][Full Text] [Related]
6. The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer.
Cheng Y; Wang M; Zhou J; Dong H; Wang S; Xu H
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33808751
[TBL] [Abstract][Full Text] [Related]
7. The N
Strick A; von Hagen F; Gundert L; Klümper N; Tolkach Y; Schmidt D; Kristiansen G; Toma M; Ritter M; Ellinger J
BJU Int; 2020 Apr; 125(4):617-624. PubMed ID: 31985880
[TBL] [Abstract][Full Text] [Related]
8. Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer.
Min L; Zhu T; Lv B; An T; Zhang Q; Shang Y; Yu Z; Zheng L; Wang Q
Int J Clin Oncol; 2022 Jun; 27(6):1013-1024. PubMed ID: 35482171
[TBL] [Abstract][Full Text] [Related]
9. The RNA N
Jin L; Chen C; Yao J; Yu Z; Bu L
Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):329-340. PubMed ID: 34717005
[TBL] [Abstract][Full Text] [Related]
10. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of m
Sun S; Han Q; Liang M; Zhang Q; Zhang J; Cao J
Thorac Cancer; 2020 Nov; 11(11):3269-3279. PubMed ID: 32956555
[TBL] [Abstract][Full Text] [Related]
12. N
Zhang C; Chen J; Ren J; Li X; Zhang Y; Huang B; Xu Y; Dong L; Cao Y
Cancer Cell Int; 2024 Mar; 24(1):96. PubMed ID: 38439072
[TBL] [Abstract][Full Text] [Related]
13. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
14. Upregulated N6-Methyladenosine RNA in Peripheral Blood: Potential Diagnostic Biomarker for Breast Cancer.
Xiao H; Fan X; Zhang R; Wu G
Cancer Res Treat; 2021 Apr; 53(2):399-408. PubMed ID: 33138349
[TBL] [Abstract][Full Text] [Related]
15. Gene Characteristics and Prognostic Values of m
Li N; Chen X; Liu Y; Zhou T; Li W
J Healthc Eng; 2021; 2021():2257066. PubMed ID: 34367534
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
Zhang Z; Yuan F; Chen R; Li Y; Ma J; Yan X; Wang L; Zhang F; Tao H; Guo D; Huang Z; Zhang S; Li X; Zhi X; Ge X; Hu Y; Wang J
Front Immunol; 2020; 11():1173. PubMed ID: 32587591
[No Abstract] [Full Text] [Related]
17. Diagnostic value of aberrant decreased 5-Methylcytosine RNA modification in leukocytes for non-small cell lung cancer.
Huang M; Ming L; Jiang H; Jiang P; Jiang X; Yin H; Hong H
J Cancer; 2023; 14(12):2198-2208. PubMed ID: 37576401
[No Abstract] [Full Text] [Related]
18. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
[TBL] [Abstract][Full Text] [Related]
19. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
Li W; Li N; Kang X; Shi K
Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.
Lv M; Li X; Yin Z; Yang H; Zhou B
PLoS One; 2024; 19(4):e0294227. PubMed ID: 38564630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]